BBI’s Dr. Danny Miller, in collaboration with other BBI faculty, has used whole-genome sequencing to assess genetic risk of a newborn by 3 hours of life, an unprecedented procedure on such a young infant and an important milestone in advancing precision medicine.
Prior to the sequencing in July, the quickest a whole human genome had been sequenced and analyzed was 8 hours.
“We can use this technology to make clinical decisions rapidly, helping clinicians determine effective treatments, and enlightening parents about their children’s genetic conditions,” said Miller, the principal investigator of the UW School of Medicine Miller Lab. “We are acquiring this important information much more rapidly than ever before.”
